CLARIPI Inc.

ClariPi Inc. is a Seoul-based medical AI software company founded in 2015 specializing in deep-learning powered CT image denoising and diagnostic analysis solutions. The company develops vendor-neutral, FDA-cleared and CE-marked software that enhances CT image clarity while enabling ultra-low-dose imaging protocols across CT scanners from any manufacturer. ClariPi's portfolio includes ClariCT.AI (core denoising engine), ClariPulmo+ (lung nodule detection and COPD analysis), ClariSIGMAM (breast density assessment), ClariAdipo (abdominal fat composition analysis), ClariMetabo (metabolic risk quantification), ClariCardio (coronary artery calcium scoring and CVD risk), ClariOsteo (bone mineral density and fracture risk), and ClariACE (AI contrast enhancement). Products integrate via DICOM protocols with existing PACS systems and clinical workflows, supporting real-time processing from desktop, embedded scanner, or cloud deployment. The company partners with major healthcare systems, OEM CT manufacturers, and imaging centers to reduce radiation exposure while maintaining diagnostic confidence through advanced noise pattern recognition trained on millions of patient images.